GS19-03a

Main Content

Impact of granulocyte colony-stimulating factor on in-vivo T-cell depleted allogeneic hematopoietic cell transplantation.

Study #: GS19-03a

Study Status: Published

Presentation(s)

2021, EBMT (Poster)

Planned granulocyte colony-stimulating factor adversely impacts survival after allogeneic hematopoietic cell transplantation performed with Thymoglobulin for myeloid malignancy.

Citation

Orfali N, Zhang M-J, Allbee-Johnson M, Boelens JJ, Artz AS, Brunstein CG, McNiece IK, Milano F, Abid MB, Chee L, Diaz MA, Grunwald MR, Hematti P, Hsu J, Lazarus HM, Munshi PN, Prestidge T, Ringden O, Rizzieri D, Riches ML, Seo S, Solh M, Solomon S, Szwajcer D, Yared J, van Besien K, Eapen M.

Transplantation and Cellular Therapy. 2021, Dec 01: 27(12): 27(12):993.e1-993.e8. doi: 10.1016/j.jtct.2021.08.031. Epub 2021, Sep 08. PMCID:PMC8671234.

PubMed

PMID: 34507002

Abstract